You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Mallinckrodt
Moodys
McKinsey
Dow

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Patent: 9,259,445

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,259,445
Title:Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure
Abstract: The present invention refers to an Integrated Implant System constituted as a gel-matrix-cells integrated system, that allows providing implants in a brief time period, for covering a great skin extension to be treated, with a successful acceptance in patients with burns, chronic damage or wound skin, needing of a skin grafting.
Inventor(s): Young Anze; Manuel Eduardo (Valparaiso, CL), Acevedo Gutierrez; Cristian Andres (Valparaiso, CL), Albornoz Marquez; Fernando Antonio (Valparaiso, CL), Weinstein Oppenheimer; Caroline Ruth (Valparaiso, CL), Aceituno Alvarez; Alexis Roobins (Valparaiso, CL), Brown Gonzalez; Donald Irving (Valparaiso, CL), Tapia Murua; Sergio Miguel (Valparaiso, CL)
Assignee: UNIVERSIDAD TECNICA FEDERICO SANTA MARIA (Valparaiso, V Region, CL) UNIVERSIDAD DE VALPARAISO (Valparaiso, V Region, CL) FUNDACION INSTITUTO DE SEGURIDAD DEL TRABAJO (Valparaiso, V Region, CL)
Application Number:12/303,714
Patent Claims:see list of patent claims

Details for Patent 9,259,445

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial UNIVERSIDAD TECNICA FEDERICO SANTA MARIA (Valparaiso, V Region, CL) UNIVERSIDAD DE VALPARAISO (Valparaiso, V Region, CL) FUNDACION INSTITUTO DE SEGURIDAD DEL TRABAJO (Valparaiso, V Region, CL) 2026-06-07 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial UNIVERSIDAD TECNICA FEDERICO SANTA MARIA (Valparaiso, V Region, CL) UNIVERSIDAD DE VALPARAISO (Valparaiso, V Region, CL) FUNDACION INSTITUTO DE SEGURIDAD DEL TRABAJO (Valparaiso, V Region, CL) 2026-06-07 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Colorcon
McKinsey
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.